Henry I. Miller


Henry I. Miller, MS, MD, was the Robert Wesson Fellow in Scientific Philosophy and Public Policy at the Hoover Institution. His research focused on public policy toward science and technology, encompassing a number of areas, including pharmaceutical development, genetic engineering in agriculture, models for regulatory reform, and the emergence of new viral diseases.

Miller served for fifteen years at the US Food and Drug Administration (FDA) in a number of posts. He was the medical reviewer for the first genetically engineered drugs to be evaluated by the FDA and thus instrumental in the rapid licensing of human insulin and human growth hormone. Thereafter, he was a special assistant to the FDA commissioner and the founding director of the FDA's Office of Biotechnology. During his government service, Miller participated frequently on various expert and policy panels as a representative of the FDA or the US government. As a government official, Miller received numerous awards and citations.

During his time at the Hoover Institution, Miller has become well known not only for his contributions to scholarly journals but also for his articles and books that make science, medicine, and technology accessible. His work has been widely published in many languages. Monographs include Policy Controversy in Biotechnology: An Insider's View; To America's Health: A Model for Reform of the Food and Drug Administration; and The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution. Barron's selected The Frankenfood Myth as one of the 25 Best Books of 2004. In addition, Miller has published extensively in a wide spectrum of scholarly journals and popular publications worldwide, including The Lancet, Journal of the American Medical Association, Science, the Nature family of journals, Chronicle of Higher Education, Forbes, National Review, Wall Street Journal, New York Times, the Guardian, Defining Ideas, and the Financial Times. He was a regulator contributor to Forbes.com and frequently appeared on the nationally syndicated radio programs of John Batchelor and Lars Larson.

Miller was selected by the editors of Nature Biotechnology as one of the people who had made the "most significant contributions" to biotechnology during the previous decade. He serves on numerous editorial boards.

Filter By:



Recent Commentary

this is an image
Analysis and Commentary

Earth Day Has Embraced Hysteria And Abandoned Science

by Henry I. Miller, Jeff Stiervia Fox News
Friday, April 20, 2018

Sunday is Earth Day, a celebration conceived by then-U.S. Senator Gaylord Nelson and first held in 1970 as a “symbol of environmental responsibility and stewardship.” In the spirit of the time, it was a touchy-feely, consciousness-raising, New Age experience. Most activities were organized at the grassroots level.

Analysis and Commentary

A 'March For Science,' Or For Political Partisanship?

by Henry I. Miller, Julie Kellyvia Washington Examiner
Friday, April 13, 2018

The March for Science on April 14, focused on Washington, D.C., and accompanied by hundreds of complementary events worldwide, promises to be an unfocused affair. According to the organizers, the marches are part of “a non-partisan movement to celebrate science and the role it plays in everyday lives.”

Viewpoint: GMO Critic Vandana Shiva's Anti-Modernity Crusade Threatens World's Poor

by Henry I. Miller, Drew L. Kershenvia Genetic Literacy Project
Thursday, April 12, 2018

The recently-published “Social Justice Warrior Handbook,” which satirizes people who promote liberal, multicultural, anti-capitalist, anti-globalization, politically correct views, could have had Indian activist and mountebank Vandana Shiva on the cover. She opposes the tools and practices of modern agriculture and science--and well, modernity in general—and advocates retrogressive policies that will cause widespread malnourishment, deprivation and death to the very people she claims to champion. 

Analysis and Commentary

Trump’s False War On Opioids Will Only Punish Patients In Pain

by Henry I. Miller, Josh Bloomvia Newsweek
Friday, April 6, 2018
The ongoing battle to control opioid addiction has not gone well, to say the least. Many of the government’s efforts, mostly from the Centers for Disease Control and Prevention (CDC), have been unproductive. Some have been counterproductive, medically and scientifically flawed, punitive, and perhaps most frightening, have usurped control of patient care from physicians.
Analysis and Commentary

Patent Foolishness On Capitol Hill

by Henry I. Miller, Jeff Stiervia Washington Examiner
Friday, April 6, 2018
Congress once again needs to correct a problem it created in the first place. But its recent attempt at a fix of the patent system is not only inadequate, but irrelevant.
Analysis and Commentary

Viewpoint: How Politics Pollutes The FDA's Genetically Modified Animal Regulations And Stifles Innovation

by Henry I. Miller, John Cohrssenvia Genetic Literacy Project
Friday, March 30, 2018

Dogs bark, cows moo, and regulators regulate,” former U.S. Food and Drug Administration commissioner Frank Young once quipped to explain regulatory agencies’ expansionist tendencies. There may be no better example than the FDA’s oversight of genetically engineered animals.

Analysis and Commentary

Why 'GMO' Is A Meaningless Term (And How To Fix That)

by Henry I. Millervia America's News HQ (Fox News)
Tuesday, March 27, 2018

There’s a saying in French, plus ça change, plus c'est la même chose, the more things change, the more they stay the same. We were reminded of that on the 30th anniversary of an op-ed about genetic engineering that we published in the Wall Street Journal when one of us (Dr. Young) headed the U.S. Food & Drug Administration and the other (Dr. Miller) was his special assistant.


John Bolton Understands That The United Nations Was Designed To Fail

by Henry I. Millervia Daily Caller (DC)
Monday, March 26, 2018

John Bolton, President Trump’s choice to succeed H.R. McMaster as his National Security Adviser, is known for not mincing words. The one-time ambassador to the United Nations once said about its headquarters: “The Secretariat building in New York has 38 stories. If it lost ten stories, it wouldn’t make a bit of difference.” Actually, it might make a lot of difference: It might be a significant improvement.

Analysis and Commentary

Not Just Elections: Russian Trolling Interference Threatens Our Infrastructure And Our Industries

by Henry I. Millervia Daily Caller (DC)
Tuesday, March 20, 2018

Russia is experienced at employing surrogates and agents of various stripes to further its agendas. The indictments instigated by independent special counsel Robert Mueller and handed down in February against three Russian entities and 13 individuals for activities related to meddling in our 2016 election shows what they are capable of: With relatively little investment and few personnel, Russian provocateurs — many in “troll factories” — were able to manipulate the platforms of some of the world’s largest and most sophisticated social-media and internet companies, including Facebook, Google and Twitter.

Analysis and Commentary

‘Right To Try’ Unapproved Drugs Advances Personal Freedom -- But Risks Must Be Taken Into Account

by Henry I. Millervia Fox News
Tuesday, March 13, 2018

Several times recently, President Trump endorsed terminally ill patients’ “right to try” drugs not approved by the FDA: “Patients with terminal conditions, terminal illness, should have access to experimental treatment immediately that could potentially save their lives,” he said in the State of the Union speech.